Rutz; Mark
Patent Applications and Registrations
Patent applications and USPTO patent grants for Rutz; Mark.The latest application filed is for "toll-like receptor 3 antagonists".
- Rutz; Mark - Martinsried DE
- Rutz; Mark - Martinsfried DE
- Rutz; Mark - Lena-Christ-Strasse N/A DE
- Rutz, Mark - Muenchen DE
| Patent | Date |
|---|---|
| Toll-like Receptor 3 Antagonists App 20180179294 - Cunningham; Mark ; et al. | 2018-06-28 |
| Methods of reducing clinical symptoms of viral infection by administering a toll-like receptor 3 antagonist Grant 9,932,404 - Cunningham , et al. April 3, 2 | 2018-04-03 |
| Toll-Like Receptor 3 Antagonists App 20170058041 - Cunningham; Mark ; et al. | 2017-03-02 |
| Method of treating an inflammatory condition by administering toll-like 3 receptor antagonists Grant 9,522,957 - Cunningham , et al. December 20, 2 | 2016-12-20 |
| Toll-like receptor 3 antagonists Grant 9,481,731 - Cunningham , et al. November 1, 2 | 2016-11-01 |
| Polynucleotides encoding Toll-Like Receptor 3 antagonists Grant 9,255,153 - Cunningham , et al. February 9, 2 | 2016-02-09 |
| Method of treating asthma or reducing inflammatory cell lung inflammation by administering toll-like receptor 3 antibodies Grant 9,238,693 - Cunningham , et al. January 19, 2 | 2016-01-19 |
| Toll-Like Receptor 3 Antagonists App 20140212426 - Cunningham; Mark ; et al. | 2014-07-31 |
| Toll-Like 3 Receptor Antagonists App 20140093508 - Cunningham; Mark ; et al. | 2014-04-03 |
| Toll-Like Receptor 3 Antagonists for the Treatment of Metabolic and Cardiovascular Diseases App 20140017250 - Cunningham; Mark ; et al. | 2014-01-16 |
| Toll-Like Receptor 3 Antagonists App 20130280263 - Cunningham; Mark ; et al. | 2013-10-24 |
| Toll-like receptor 3 antagonists Grant 8,540,986 - Cunningham , et al. September 24, 2 | 2013-09-24 |
| Toll-Like Receptor 3 Antagonists App 20130244281 - Cunningham; Mark ; et al. | 2013-09-19 |
| IL-17A antibodies Grant 8,519,107 - Almagro , et al. August 27, 2 | 2013-08-27 |
| Toll-like receptor 3 antagonists for the treatment of metabolic and cardiovascular diseases Grant 8,460,659 - Cunningham , et al. June 11, 2 | 2013-06-11 |
| Toll-Like Receptor 3 Antagonists for the Treatment of Metabolic and Cardiovascular Diseases App 20130090457 - Cunningham; Mark ; et al. | 2013-04-11 |
| Toll-like receptor 3 antagonists Grant 8,409,567 - Cunningham , et al. April 2, 2 | 2013-04-02 |
| Toll-like Receptor 3 Antagonists For The Treatment Of Metabolic And Cardiovascular Diseases App 20120064095 - Cunningham; Mark ; et al. | 2012-03-15 |
| IL-17A Antagonists App 20110236390 - Almagro; Juan Carlos ; et al. | 2011-09-29 |
| Toll-Like Receptor 3 Antagonists App 20110008352 - Cunningham; Mark ; et al. | 2011-01-13 |
| Toll-Like Receptor 3 Antagonists App 20100166778 - Cunningham; Mark ; et al. | 2010-07-01 |
| Cell-free methods for identifying compounds that affect toll-like receptor 9 (TLR9) signaling App 20050100983 - Bauer, Stefan ; et al. | 2005-05-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 